Presentation is loading. Please wait.

Presentation is loading. Please wait.

The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome  Sarantis Livadas,

Published byἸωσῆς Αλιβιζάτος Modified over 6 years ago

Similar presentations

Presentation on theme: "The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome  Sarantis Livadas,"— Presentation transcript:

1 The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome  Sarantis Livadas, M.D., Georgios Boutzios, M.D., Fragiskos Economou, M.D., Krystallenia Alexandraki, M.D., Xenofon Xyrafis, M.D., Maria Christou, M.D., Aristea Zerva, M.D., Athanasios Karachalios, M.D., Evangelia Tantalaki, M.D., Evanthia Diamanti-Kandarakis, M.D.  Fertility and Sterility  Volume 94, Issue 1, Pages (June 2010) DOI: /j.fertnstert Copyright © Terms and Conditions

2 Figure 1 Fluctuation of 17α-hydroxyprogesterone (17OHP) between subjects in the three studied intervals. ∗Statistical significance (P<.05), between baseline and day 8. #Statistical significance (P<.05), between baseline and day 21. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

3 Figure 2 Fluctuation of homeostasis assessment model (HOMA-IR) between subjects in the three studied intervals. ∗Statistical significance (P<.05), between baseline and day 8. #Statistical significance (P<.05), between baseline and day 21. Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © Terms and Conditions

Download ppt "The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome  Sarantis Livadas,"

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Charles J. Glueck, M. D. , Joel Pranikoff, M. D. , Dawit Aregawi, M. D

Charles J. Glueck, M. D. , Joel Pranikoff, M. D. , Dawit Aregawi, M. D
Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice  Lysanne.
Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D. 
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Alison Berent-Spillson, Ph. D. , Tiffany Love, Ph. D

Alison Berent-Spillson, Ph. D. , Tiffany Love, Ph. D
The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,

The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,
The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome  Silvia Ajossa, M.D., Stefano Guerriero, M.D.,

The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome  Silvia Ajossa, M.D., Stefano Guerriero, M.D.,
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report  Ricardo Azziz, M.D., M.P.H., Enrico Carmina,

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report  Ricardo Azziz, M.D., M.P.H., Enrico Carmina,
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis  Anuja Dokras, M.D., Ph.D., Shari.
Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,

Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women  Babak Mokhlesi, M.D.,
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A

Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.

Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study  Cem Celik, M.D., Nicel.
Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome 

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome 
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 

Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,

Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.
Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system  Shan Liu, M.D.,

Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system  Shan Liu, M.D.,
Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.

Is the addition of metformin efficacious in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome? A structured literature.

Similar presentations

Ads by Google